Epidemiological Characteristics and Antimicrobial Resistance Changes of Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii under the COVID-19 Outbreak: An Interrupted Time Series Analysis in a Large Teaching Hospital
Open Access
- 22 February 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (3) , 431
Abstract
Background: To investigate the epidemiological characteristics and resistance changes of carbapenem-resistant organisms (CROs) under the COVID-19 outbreak to provide evidence for precise prevention and control measures against hospital-acquired infections during the pandemic. Methods: The distribution characteristics of CROs (i.e., carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii) were analyzed by collecting the results of the antibiotic susceptibility tests of diagnostic isolates from all patients. Using interrupted time series analysis, we applied Poisson and linear segmented regression models to evaluate the effects of COVID-19 on the numbers and drug resistance of CROs. We also conducted a stratified analysis using the Cochran–Mantel–Haenszel test. Results: The resistance rate of carbapenem-resistant Acinetobacter baumannii (CRAB) was 38.73% higher after the COVID-19 outbreak compared with before (p < 0.05). In addition, the long-term effect indicated that the prevalence of CRAB had a decreasing trend (p < 0.05). However, the overall resistance rate of Klebsiella pneumoniae did not significantly change after the COVID-19 outbreak. Stratified analysis revealed that the carbapenem-resistant Klebsiella pneumoniae (CRKP) rate increased in females (OR = 1.98, p < 0.05), those over 65 years old (OR = 1.49, p < 0.05), those with sputum samples (OR = 1.40, p < 0.05), and those in the neurology group (OR = 2.14, p < 0.05). Conclusion: The COVID-19 pandemic has affected the change in nosocomial infections and resistance rates in CROs, highlighting the need for hospitals to closely monitor CROs, especially in high-risk populations and clinical departments. It is possible that lower adherence to infection control in crowded wards and staffing shortages may have contributed to this trend during the COVID-19 pandemic, which warrants further research.Keywords
Funding Information
- The National Natural Science Foundation of China (72204275, 72074234, CMB-OC-19-337, 2021A1515110364, 2022A1515011338)
- China Medical Board (72204275, 72074234, CMB-OC-19-337, 2021A1515110364, 2022A1515011338)
- Guangdong Basic and Applied Basic Research Foundation (72204275, 72074234, CMB-OC-19-337, 2021A1515110364, 2022A1515011338)
This publication has 30 references indexed in Scilit:
- Neuropsychiatric aspects of COVID-19 pandemic: A selective reviewAsian Journal of Psychiatry, 2020
- Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?Journal of Clinical Medicine, 2020
- Control of a hospital-wide outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB) using the Israeli national carbapenem-resistant Enterobacteriaceae (CRE) guidelines as a modelInfection Control & Hospital Epidemiology, 2020
- Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?Clinical Infectious Diseases, 2020
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018Emerging Microbes & Infections, 2020
- The prevalence of the culturable human skin aerobic bacteria in Riyadh, Saudi ArabiaBMC Microbiology, 2019
- Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomesInternational Journal of Infectious Diseases, 2015
- Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteriaClinical Microbiology and Infection, 2012